Close

Janssen to Showcase Data from Five Compounds Including Daratumumab and IMBRUVICA at ASCO (JNJ)

May 13, 2015 5:22 PM EDT Send to a Friend
Janssen Research & Development, LLC (Janssen) announced that data from five oncology treatments across the portfolio, including marketed and investigational ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login